Definitive Contract 266030017
Award Date 6/1/04
Potential Completion Date 1/8/07
Potential Value $13M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Austria
Solicitation Procedures
Not listed
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Sanofi Pasteur Biologics, LLC for the production and testing of a Modified Vaccinia Ankara (MVA) vaccine. The contract award has a ceiling value of $74,940,566.62 and an ultimate completion date of February 6, 2015. The contract is not designated as a set-aside. As a child company of the Sanofi group, Sanofi...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods, to provide research and development facilities. The contract, valued at $8,045,553.00, is a definitive contract without a set-aside designation, with an ultimate completion date of December 30, 2009. The funding agency is the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. In addition to this contract, Sanofi...
- This is a modification to a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit organization. The original contract was awarded on September 30, 2005 with a ceiling value of $6,030,142.00 and a period of performance through July 31, 2007. This modification is to cancel the unbilled funds associated with the expired fiscal year 2002 contract and project....
- This federal contract award is for the provision of VACCINES to a U.S. government agency. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods and medical supplies. The contract has a total ceiling value of $582,081.35 and was awarded on a firm fixed price basis without any set-aside designation. The award is associated with a larger Indefinite Delivery Vehicle (IDV) potentially valued at $5.87 billion that Sanofi Pasteur holds with the...
- This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Sanofi Pasteur Inc. to provide vaccines for stock. The contract has a ceiling value of $120,272.19 and a performance period ending on May 23, 2015. As the prime contractor, Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of goods that has received numerous awards from government agencies, including the Department of Veterans Affairs,...
- This is a $26,065,720.00 cost-plus-fixed-fee delivery order awarded to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is for the manufacture of human flu challenge material, which supports IAVI's mission to develop safe and effective preventive vaccines for infectious diseases. The award is part of IAVI's existing indefinite...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Janssen Vaccines & Prevention B.V. (doing business as JPC), a foreign-owned for-profit organization. The contract is for the "Application of Platform Technologies for the Development of Therapeutics for Biodefense" and has a ceiling value of $100,958,063.00. The contract type is Cost Plus Fixed Fee, with an ultimate completion date of August 14, 2014. The...
- This federal contract award was made by the Office of the Assistant Secretary for Administration, a civilian agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods. The award, valued at $119,970.07, is for the delivery of SANOFI VACCINES FOR STOCK, with an ultimate completion date of August 23, 2015. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Sanofi Pasteur Inc. is an experienced federal contractor, holding several Indefinite...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the production of influenza virus vaccines. The contract, awarded by the Medical Supply Chain division of the Defense agency, is a delivery order with a firm fixed price of $3,150,107.50 and an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various...
- This federal contract award is for the delivery of influenza virus vaccines. The contract was awarded to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production and medical supplies. The contract has a ceiling value of $860,411.20 and was awarded by the U.S. Department of Defense on July 3, 2025, with an ultimate completion date of September 26, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside...